Clostridium difficile Testing Algorithm: Is There a Difference in Patients Who Test Positive by Enzyme Immunoassay vs. Those Who Only Test Positive by Nucleic Acid Amplification Methodology?

BACKGROUND: Testing for Clostridium difficile infection (CDI) commonly involves checking for the presence of toxins A and B by enzyme immunoassay (EIA) or nucleic acid amplification (NAA). The former is very specific, but not very sensitive. The latter is very sensitive. Beginning in 2011, our hospi...

Descripción completa

Detalles Bibliográficos
Autores principales: Polak, Jonathan, Odili, Ogheneruona, Craver, Mary Ashleigh, Mayen, Anthony, Purrman, Kyle, Rahman, Asem, Sang, Charlie Joseph, Cook, Paul P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631102/
http://dx.doi.org/10.1093/ofid/ofx163.981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631102/
http://dx.doi.org/10.1093/ofid/ofx163.981

Ejemplares similares